Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis

Molecular and Cellular Biology

Volumn 34, Issue 9, 2014, Pages 1707-1719

  Soshilov, Anatoly A ^a   Denison, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; 3,3',4,4',5 PENTACHLOROBIPHENYL; ALPHA NAPHTHOFLAVONE; AMINO ACID; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; HEAT SHOCK PROTEIN 90; INDIRUBIN; ISOLEUCINE; LIGAND; METHIONINE; PHENYLALANINE DERIVATIVE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; ENANTIOSELECTIVITY; GENE INDUCTION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MOUSE; MUTANT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL LINE; HSP90 HEAT-SHOCK PROTEINS; LIGANDS; MICE; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON;

EID: 84897476165     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01183-13     Document Type: Article

References (66)

1. DeGroot DE, He G, Fraccalvieri D, Bonati L, Pandini A, Denison MS. 2011. AhR ligands: promiscuity in binding and diversity in response, p 63-79. In Pohjanvirta R (ed), The AH receptor in biology and toxicology. Wiley, Hoboken, NJ.
2. Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B. 2011. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124:1-22. http://dx.doi.org/10.1093/toxsci/kfr218.
3. NTP. 2011. 12th report on carcinogens. Department of Health, Human Services, National Toxicology Program, Research Triangle Park, NC.
4. White SS, Birnbaum LS. 2009. An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27:197-211. http://dx.doi.org/10.1080/10590500903310047.
5. Berghard A, Gradin K, Toftgård R. 1992. The stability of dioxin-receptor ligands influences cytochrome P450IA1 expression in human keratinocytes. Carcinogenesis 13:651-655. http://dx.doi.org/10.1093/carcin/13.4.651.
6. Kim MJ, Pelloux V, Guyot E, Tordjman J, Bui LC, Chevallier A, Forest C, Benelli C, Clement K, Barouki R. 2012. Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environ. Health Perspect. 120:508-514. http://dx.doi.org/10.1289/ehp.1104282.
7. Riddick DS, Huang Y, Harper PA, Okey AB. 1994. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1. J. Biol. Chem. 269:12118-12128.
8. Coumailleau P, Poellinger L, Gustafsson JA, Whitelaw ML. 1995. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J. Biol. Chem. 270:25291-25300. http://dx.doi.org/10.1074/jbc.270.42.25291.
9. Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O. 1995. Identification of functional domains of the aryl hydrocarbon receptor. J. Biol. Chem. 270:29270-29278. http://dx.doi.org/10.1074/jbc.270.49.29270.
10. Soshilov A, Denison MS. 2011. Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain. J. Biol. Chem. 286:35275-35282. http://dx.doi.org/10.1074/jbc.M111.246439.
11. Chen HS, Singh SS, Perdew GH. 1997. The Ah receptor is a sensitive target of geldanamycin-induced protein turnover. Arch. Biochem. Biophys. 348:190-198. http://dx.doi.org/10.1006/abbi.1997.0398.
12. Henry EC, Gasiewicz TA. 1993. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzop-dioxin. Biochem. J. 294(Part 1):95-101.
13. Pongratz I, Mason GG, Poellinger L. 1992. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J. Biol. Chem. 267:13728-13734.
14. Probst MR, Reisz-Porszasz S, Agbunag RV, Ong MS, Hankinson O. 1993. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44:511-518.
15. Denison MS, Phelps CL, Dehoog J, Kim HJ, Bank PA, Yao EF. 1991. Species variation in Ah receptor transformation andDNAbinding, p 337-349. In Gallo MA, Scheuplein RJ, Van Der Heijden KA (ed), Banbury report no. 35: biological basis of risk assessment of dioxins and related compounds. Cold Spring Harbor Press, Cold Spring Harbor, NY.
16. Denison MS, Fisher JM, Whitlock JP, Jr. 1988. The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem. 263:17221-17224.
17. Bunger MK, Glover E, Moran SM, Walisser JA, Lahvis GP, Hsu EL, Bradfield CA. 2008. Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicol. Sci. 106:83-92. http://dx.doi.org/10.1093/toxsci/kfn149.
18. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. 2008. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71. http://dx.doi.org/10.1038/nature06880.
19. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP. 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329:1345-1348. http://dx.doi.org/10.1126/science.1191536.
20. Gramatzki D, Pantazis G, Schittenhelm J, Tabatabai G, Kohle C, Wick W, Schwarz M, Weller M, Tritschler I. 2009. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene 28:2593-2605. http://dx.doi.org/10.1038/onc.2009.104.
21. Goodale BC, Tilton SC, Corvi MM, Wilson GR, Janszen DB, Anderson KA, Waters KM, Tanguay RL. 2013. Structurally distinct polycyclic aromatic hydrocarbons induce differential transcriptional responses in developing zebrafish. Toxicol. Appl. Pharmacol. 272:656-670. http://dx.doi.org/10.1016/j.taap.2013.04.024.
22. Hrubá E, Vondráček J, Líbalová H, Topinka J, Bryja V, Souček K, Machala M. 2011. Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands. Toxicol. Lett. 206:178-188. http://dx.doi.org/10.1016/j.toxlet.2011.07.011.
23. Ovando BJ, Ellison CA, Vezina CM, Olson JR. 2010. Toxicogenomic analysis of exposure to TCDD, PCB126, and PCB153: identification of genomic biomarkers of exposure to AhR ligands. BMC Genomics 11:583. http://dx.doi.org/10.1186/1471-2164-11-583.
24. Gouedard C, Barouki R, Morel Y. 2004. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptordependent mechanism. Mol. Cell. Biol. 24:5209-5222. http://dx.doi.org/10.1128/MCB.24.12.5209-5222.2004.
25. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, Tilly JL. 2001. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat. Genet. 28:355-360. http://dx.doi.org/10.1038/ng575.
26. Murray IA, Morales JL, Flaveny CA, DiNatale BC, Chiaro C, Gowdahalli K, Amin S, Perdew GH. 2010. Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 77:247-254. http://dx.doi.org/10.1124/mol.109.061788.
27. Zhang S, Rowlands C, Safe S. 2008. Ligand-dependent interactions of the Ah receptor with coactivators in a mammalian two-hybrid assay. Toxicol. Appl. Pharmacol. 227:196-206. http://dx.doi.org/10.1016/j.taap.2007.10.019.
28. Ngan C-H, Beglov D, Rudnitskaya AN, Kozakov D, Waxman DJ, Vajda S. 2009. The structural basis of pregnane X receptor binding promiscuity. Biochemistry 48:11572-11581. http://dx.doi.org/10.1021/bi901578n.
29. Ekins S, Chang C, Mani S, Krasowski MD, Reschly EJ, Iyer M, Kholodovych V, Ai N, Welsh WJ, Sinz M, Swaan PW, Patel R, Bachmann K. 2007. Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol. Pharmacol. 72:592-603. http://dx.doi.org/10.1124/mol.107.038398.
30. Mani S, Dou W, Redinbo MR. 2013. PXR antagonists and implication in drug metabolism. Drug Metab. Rev. 45:60-72. http://dx.doi.org/10.3109/03602532.2012.746363.
31. Zhao B, Degroot DE, Hayashi A, He G, Denison MS. 2010. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol. Sci. 117:393-403. http://dx.doi.org/10.1093/toxsci/kfq217.
32. Motto I, Bordogna A, Soshilov AA, Denison MS, Bonati L. 2011. New aryl hydrocarbon receptor homology model targeted to improve docking reliability. J. Chem. Inf. Model. 51:2868-2881. http://dx.doi.org/10.1021/ci2001617.
33. Pandini A, Soshilov AA, Song Y, Zhao J, Bonati L, Denison MS. 2009. Detection of the TCDD binding-fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis. Biochemistry 48:5972-5983. http://dx.doi.org/10.1021/bi900259z.
34. Backlund M, Ingelman-Sundberg M. 2004. Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high-and low-affinity ligand binding and receptor activation. Mol. Pharmacol. 65:416-425. http://dx.doi.org/10.1124/mol.65.2.416.
35. Goryo K, Suzuki A, Carpio CAD, Siizaki K, Kuriyama E, Mikami Y, Kinoshita K, Yasumoto K-I, Rannug A, Miyamoto A, Fujii-Kuriyama Y, Sogawa K. 2007. Identification of amino acid residues in the Ah receptor involved in ligand binding. Biochem. Biophys. Res. Commun. 354:396-402. http://dx.doi.org/10.1016/j.bbrc.2006.12.227.
36. Whelan F, Hao N, Furness SGB, Whitelaw ML, Chapman-Smith A. 2010. Amino acid substitutions in the aryl hydrocarbon receptor ligand binding domain reveal YH439 as an atypical AhR activator. Mol. Pharmacol. 77:1037-1046. http://dx.doi.org/10.1124/mol.109.062927.
37. Poland A, Palen D, Glover E. 1994. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46:915-921.
38. Fukunaga BN, Hankinson O. 1996. Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding. J. Biol. Chem. 271:3743-3749. http://dx.doi.org/10.1074/jbc.271.7.3743.
39. Soshilov A, Denison MS. 2008. Role of the Per/Arnt/Sim domains in ligand-dependent transformation of the aryl hydrocarbon receptor. J. Biol. Chem. 283:32995-33005. http://dx.doi.org/10.1074/jbc.M802414 200.
40. Karchner SI, Franks DG, Kennedy SW, Hahn ME. 2006. The molecular basis for differential dioxin sensitivity in birds: role of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 103:6252-6257. http://dx.doi.org/10.1073/pnas.0509950103.
41. Rushing SR, Denison MS. 2002. The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression. Arch. Biochem. Biophys. 403:189-201. http://dx.doi.org/10.1016/S0003-9861(02)00233-3.
42. Wincent E, Bengtsson J, Mohammadi Bardbori A, Alsberg T, Luecke S, Rannug U, Rannug A. 2012. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 109:4479-4484. http://dx.doi.org/10.1073/pnas.1118467109.
43. Rannug U, Rannug A, Sjoberg U, Li H, Westerholm R, Bergman J. 1995. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 2:841-845.
44. Scheuermann TH, Tomchick DR, Machius M, Guo Y, Bruick RK, Gardner KH. 2009. Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor. Proc. Natl. Acad. Sci. U. S. A. 106:450-455. http://dx.doi.org/10.1073/pnas.0808092106.
45. Goodale BC, La Du JK, Bisson WH, Janszen DB, Waters KM, Tanguay RL. 2012. Ahr2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafish. PLoS One 7:e29346. http://dx.doi.org/10.1371/journal.pone.0029346.
46. O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK. 2010. The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One 5:e13128. http://dx.doi.org/10.1371/journal.pone.0013128.
47. Blank JA, Tucker AN, Sweatlock J, Gasiewicz TA, Luster MI. 1987. Alpha-naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-pdioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol. Pharmacol. 32:169-172.
48. Santostefano M, Merchant M, Arellano L, Morrison V, Denison MS, Safe S. 1993. Alpha-naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol. Pharmacol. 43:200-206.
49. Lu YF, Santostefano M, Cunningham BD, Threadgill MD, Safe S. 1995. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch. Biochem. Biophys. 316:470-477. http://dx.doi.org/10.1006/abbi.1995.1062.
50. Zhou J, Gasiewicz TA. 2003. 3'-Methoxy-4'-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism. Arch. Biochem. Biophys. 416:68-80. http://dx.doi.org/10.1016/S0003-9861(03)00274-1.
51. Perdew GH. 1988. Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263:13802-13805.
52. Antonsson C, Whitelaw ML, McGuire J, Gustafsson JA, Poellinger L. 1995. Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains. Mol. Cell. Biol. 15:756-765.
53. Gouedard C, Barouki R, Morel Y. 2004. Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler. Thromb Vasc. Biol. 24:2378-2383. http://dx.doi.org/10.1161/01.ATV.0000146530.24736.ce.
54. Murray IA, Flaveny CA, Chiaro CR, Sharma AK, Tanos RS, Schroeder JC, Amin SG, Bisson WH, Kolluri SK, Perdew GH. 2011. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-alphanaphthoflavone. Mol. Pharmacol. 79:508-519. http://dx.doi.org/10.1124/mol.110.069369.
55. Murray IA, Krishnegowda G, DiNatale BC, Flaveny C, Chiaro C, Lin JM, Sharma AK, Amin S, Perdew GH. 2010. Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits antiinflammatory properties. Chem. Res. Toxicol. 23:955-966. http://dx.doi.org/10.1021/tx100045h.
56. Chen I, McDougal A, Wang F, Safe S. 1998. Aryl hydrocarbon receptormediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19:1631-1639. http://dx.doi.org/10.1093/carcin/19.9.1631.
57. McDougal A, Wilson C, Safe S. 1997. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Lett. 120:53-63. http://dx.doi.org/10.1016/S0304-3835(97)00299-1.
58. Huang G, Elferink CJ. 2012. A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression. Mol. Pharmacol. 81:338-347. http://dx.doi.org/10.1124/mol.111.075952.
59. Petkov PI, Rowlands JC, Budinsky R, Zhao B, Denison MS, Mekenyan O. 2010. Mechanism-based common reactivity pattern (COREPA) modelling of aryl hydrocarbon receptor binding affinity. SAR QSAR Environ. Res. 21:187-214. http://dx.doi.org/10.1080/10629360903570933.
60. Fraccalvieri D, Soshilov AA, Karchner SI, Franks DG, Pandini A, Bonati L, Hahn ME, Denison MS. 2013. Comparative analysis of homology models of the Ah receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctionalreceptor. Biochemistry52:714-725.http://dx.doi.org/10.1021/bi301 457f.
61. Eisenberg D, McLachlan AD. 1986. Solvation energy in protein folding and binding. Nature 319:199-203. http://dx.doi.org/10.1038/319199a0.
62. Flaveny CA, Perdew GH. 2009. Transgenic humanized AhR mouse reveals differences between human and mouse AhR ligand selectivity. Mol. Cell. Pharmacol. 1:119-123. http://dx.doi.org/10.4255/mcphar macol.09.15.
63. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M. 2011. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197-203. http://dx.doi.org/10.1038/nature10491.
64. Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA. 2006. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch. Biochem. Biophys. 450:67-77. http://dx.doi.org/10.1016/j.abb.2006.02.008.
65. Savouret J-F, Antenos M, Quesne M, Xu J, Milgrom E, Casper RF. 2001. 7-Ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J. Biol. Chem. 276:3054-3059. http://dx.doi.org/10.1074/jbc.M005988200.
66. Phelan D, Winter GM, Rogers WJ, Lam JC, Denison MS. 1998. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys. 357:155-163. http://dx.doi.org/10.1006/abbi.1998.0814.